Increasing serum albumin in patients with hypoalbuminemia does not inhibit serum angiotensin-converting enzyme activity Serum Albumin Increase and Serum ACE Activity in Hypoalbuminemic Patients
Student Research in Translational Medicine,
Vol. 5 (2023),
30 December 2023
https://doi.org/10.22037/srtm.v5.44341
Abstract
Introduction: Angiotensin-converting enzyme (ACE) plays a pivotal role in the production of angiotensin II and the inactivation of bradykinin. Recent studies have suggested that human serum albumin may possess ACE-inhibitory properties, serving as a potential endogenous ACE inhibitor that primarily affects serum ACE levels. Interestingly, the infusion of albumin in the postoperative phase of cardiac surgery has been associated with the development of hypotension.
Methods: This study aimed to assess serum ACE activity in 27 hypoalbuminemia patients admitted to the ICU before and after a protein-rich diet was administered to raise their serum albumin levels. Serum ACE activity was quantified using raas(HPLC), measuring the formation of hippuric acid, a product generated during the incubation of serum with Hip-His-Leu, a substrate, at 37°C for 30 minutes.
Results: In vitro experiments demonstrated that the addition of albumin to human sera led to a significant reduction in ACE activity compared to control groups (P < 0.0001). This reduction was consistent across all serum samples. Specifically, the maximum velocity (Vmax) of ACE activity significantly decreased from 14.90 U/L in the control group to 3.210 U/L in the albumin-added group (P = 0.0262). Notably, there was no significant change in the Michaelis constant (Km) between the control group (0.5263 mM) and the albumin group (0.2742 mM) (P = 0.6763), indicating a non-competitive inhibitory effect of albumin on ACE activity. Interestingly, in this study, elevating serum albumin levels in hypoalbuminemia patients following a protein-rich diet resulted in both ACE inhibition and a slight increase in activity (P = 0.0201). This increase correlated mildly with serum albumin levels across all samples.
Conclusions: In conclusion, contrary to in vitro findings, raising serum albumin levels in hypoalbuminemia patients did not further inhibit serum ACE activity.
- Angiotensin-converting enzyme
- ACE activity
- ACE inhibitor
- Human serum albumin
How to Cite
References
Atlas SA.The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition.J Manag Care Pharm.2007;13(8 Suppl B):9-20.
Ryan JW, Martin LC, Chung A and Pena GA.Mammalian inhibitors of angiotensin converting enzyme (kininase II).Adv Exp Med Biol.1979;120B:599-606.
Snyder RA and Wintroub BU.Inhibition of angiotensin-converting enzyme by des-Leu10-angiotensin I: a potential mechanism of endogenous angiotensin-converting enzyme regulation.Biochim Biophys Acta.1986;871(1):1-5.
Rogerson FM, Livett BG, Scanlon D and Mendelsohn FA.Inhibition of angiotensin converting enzyme by N-terminal fragments of substance P.Neuropeptides.1989;14(4):213-7.
Nakagomi K, Yamada R, Ebisu H, Sadakane Y, Akizawa T and Tanimura T.Isolation of acein-2, a novel angiotensin-I-converting enzyme inhibitory peptide derived from a tryptic hydrolysate of human plasma.FEBS Lett.2000;467(2-3):235-8.
Lieberman J and Sastre A.An angiotensin-converting enzyme (ACE) inhibitor in human serum. Increased sensitivity of the serum ACE assay for detecting active sarcoidosis.Chest.1986;90(6):869-75.
Ikemoto F, Song GB, Tominaga M and Yamamoto K.Endogenous inhibitor of angiotensin converting enzyme in the rat heart.Biochem Biophys Res Commun.1989;159(3):1093-9.
Fagyas M, Uri K, Siket IM, Fulop GA, Csato V, Darago A, et al.New perspectives in the renin-angiotensin-aldosterone system (RAAS) II: albumin suppresses angiotensin converting enzyme (ACE) activity in human.PLoS One.2014;9(4):e87844.
Fagyas M, Uri K, Siket IM, Darago A, Boczan J, Banyai E, et al.New perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogenous inhibition of angiotensin converting enzyme (ACE) provides protection against cardiovascular diseases.PLoS One.2014;9(4):e93719.
Assaran Darban R, Shareghi B, Asoodeh A and Chamani J.Multi-spectroscopic and molecular modeling studies of interaction between two different angiotensin I converting enzyme inhibitory peptides from gluten hydrolysate and human serum albumin.Journal of Biomolecular Structure and Dynamics.2017;35(16):3648-62.
Ziai SA, Salehian P and Mahmoudian M.Study of serum and tissues angiotensin converting enzyme (ACE) activity in rat with gentamicin induced renal toxicity.Ren Fail.2003;25(6):923-33.
Agerholm-Larsen B, Nordestgaard BG and Tybjaerg-Hansen A.ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites.Arterioscler Thromb Vasc Biol.2000;20(2):484-92.
Kramers C, Danilov SM, Deinum J, Balyasnikova IV, Scharenborg N, Looman M, et al.Point mutation in the stalk of angiotensin-converting enzyme causes a dramatic increase in serum angiotensin-converting enzyme but no cardiovascular disease.Circulation.2001;104(11):1236-40.
Nesterovitch AB, Hogarth KD, Adarichev VA, Vinokour EI, Schwartz DE, Solway J, et al.Angiotensin I-converting enzyme mutation (Trp1197Stop) causes a dramatic increase in blood ACE.PLoS One.2009;4(12):e8282.
Fagyas M, Uri K, Siket IM, Darago A, Boczan J, Banyai E, et al.New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition.PLoS One.2014;9(4):e87843.
Shakerian M, Razavi SH, Ziai SA, Khodaiyan F, Yarmand MS and Moayedi A.Proteolytic and ACE-inhibitory activities of probiotic yogurt containing non-viable bacteria as affected by different levels of fat, inulin and starter culture.Journal of Food Science and Technology.2015;52(4):2428-33.
Ziai S, Rezazadeh S, Dastpak A, Shabestari A, Taghizadeh M, Naghdibadi H, et al.Study of the ACE inhibitory effect of medicinal plants used in Iranian folk-medicine as antihypertensive remedy.Journal of Medicinal Plants.2006;4(20):53-74.
Eff ARY, Rahayu ST, Mahayasih PG and Januarko MU.Standardization of Indonesian Traditional Antihypertensive Medicines (Jamu) through the ACE Inhibitor Mechanism.Pharmacognosy Journal.2020;12(3).
Modak P, Halder S, Sarkar BK, Das A, Sarkar AP and Kundu SK.TRADITIONAL ANTIHYPERTENSIVE MEDICINAL PLANTS: A COMPREHENSIVE REVIEW.2020.
Lange-Jacobs D, Shaikh-Kader A, Thomas B and Nyakudya TT.An Overview of the Potential Use of Ethno-Medicinal Plants Targeting the Renin–Angiotensin System in the Treatment of Hypertension.Molecules.2020;25(9):2114.
Sharifi N, Souri E, Ziai SA, Amin G, Amini M and Amanlou M.Isolation, identification and molecular docking studies of a new isolated compound, from Onopordon acanthium: a novel angiotensin converting enzyme (ACE) inhibitor.J Ethnopharmacol.2013;148(3):934-9.
Sharifi N, Souri E, Ziai SA, Amin G and Amanlou M.Discovery of new angiotensin converting enzyme (ACE) inhibitors from medicinal plants to treat hypertension using an in vitro assay.DARU Journal of Pharmaceutical Sciences.2013;21(1):74.
Maruyama S, Suzuki HJA and Chemistry B.A peptide inhibitor of angiotensin I converting enzyme in the tryptic hydrolysate of casein.1982;46(5):1393-94.
Klauser RJ, Robinson CJ, Marinkovic DV and Erdos EG.Inhibition of human peptidyl dipeptidase (angiotensin I converting enzyme: kininase II) by human serum albumin and its fragments.Hypertension.1979;1(3):281-6.
Howard G, Downward G and Bowie D.Human serum albumin induced hypotension in the postoperative phase of cardiac surgery.Anaesth Intensive Care.2001;29(6):591-4.
Vincent JL.Relevance of albumin in modern critical care medicine.Best Pract Res Clin Anaesthesiol.2009;23(2):183-91.
Cushman DW and Cheung HS.Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung.Biochem Pharmacol.1971;20(7):1637-48.
CARMEL A and YARON A.An intramolecularly quenched fluorescent tripeptide as a fluorogenic substrate of angiotensin‐i‐converting enzyme and of bacterial dipeptidyl carboxypeptidase.European journal of biochemistry.1978;87(2):265-73.
Sentandreu MÁ and Toldrá F.A rapid, simple and sensitive fluorescence method for the assay of angiotensin-I converting enzyme.Food chemistry.2006;97(3):546-54.
Rohrbach MS.[Glycine-1-14C] hippuryl-l-histidyl-l-leucine: A substrate for the radlochemical assay of angiotensin converting enzyme.Analytical Biochemistry.1978;84(1):272-76.
Chiknas SG.A liquid chromatography-assisted assay for angiotensin-converting enzyme (peptidyl dipeptidase) in serum.Clin Chem.1979;25(7):1259-62.
Ferrario CM, Dell’Italia LJ and Varagic J.Molecular Signaling ChapterMechanismsTitle Oneof the Line.Heart Failure: A Companion to Braunwald's Heart Disease.2019:76.
- Abstract Viewed: 127 times
- PDF Downloaded: 46 times
